Inhibition of endothelin-B receptor signaling synergizes with MAPK pathway inhibitors in BRAF mutated melanoma.
Oncogene. 2021 Mar;40(9):1659-1673. doi: 10.1038/s41388-020-01628-x. Epub 2021 Jan 26.
Oncogene. 2021.
PMID: 33500549